Cintredekin besudotox
N/A
Report date: 2022/07/19 16:22:54
Base Information
Drug NameCintredekin besudotox
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesInsys Therapeutics IncNational Cancer InstituteNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive Indications +[6]